EMCURE.NS
EMCURE.NS
INE168P01015
EMCURE PHARMACEUTICALS L
Loading chart...

Company Profile

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynaecology, cardiovascular, blood-related, pain and analgesics, oncology/anti-neoplastics, anti-infectives, vitamins, minerals and nutrients, respiratory, HIV antivirals, Metabolics, gastro, anti-diabetic, neuro, derma, and mRNA vaccine. It provides its products under Orofer-Xt, Zostum, Bevon, Amaryl M, Orofer Fcm, Maxtra, Clexane, Metpure-Xl, Amaryl, Spegra, Feronia-Xt, Cardace, Pause, Lornit, Targocid, Orofer-S, Lasilactone, Gros, Orofer-Xt Liq, And Tenectase brand names. Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.

Related stocks

IPCALAB.NS
IPCALAB.NS • India
IPCA LABORATORIES LTD
1,915.4 INR
5.02B USD 1Y +43%
ABBOTINDIA.NS
ABBOTINDIA.NS • India
ABBOTT INDIA LIMITED
26,000 INR
5.71B USD 1Y -14.5%
AJANTPHARM.NS
AJANTPHARM.NS • India
AJANTA PHARMA LIMITED
3,410.1 INR
4.4B USD 1Y +40.8%
GRANULES.NS
GRANULES.NS • India
GRANULES INDIA LIMITED
815.25 INR
2.3B USD 1Y +48.5%
NEULANDLAB.BO
NEULANDLAB.BO • India
NEULAND LABORATORIES LTD.
20,879.85 INR
2.77B USD 1Y +35.8%
ERIS.NS
ERIS.NS • India
ERIS LIFESCIENCES LIMITED
1,170.7 INR
1.68B USD 1Y -27.8%
PPLPHARMA.NS
PPLPHARMA.NS • India
PIRAMAL PHARMA LIMITED
196.88 INR
2.7B USD 1Y -0.4%
ALIVUS.NS
ALIVUS.NS • India
ALIVUS LIFE SCIENCES LTD
1,326.3 INR
1.68B USD 1Y +45.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
35.4% p.a.
Max Drawdown (3Y)
-40.7%
Sharpe Ratio (3Y)
0.33
Beta Factor
-0.08
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
ende